Related Experiment Video

Updated: Aug 15, 2026

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures

A W Dove1, V R Racaniello

  • 1Department of Microbiology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

Journal of Virology
|March 23, 2000
PubMed

Insights

WIN51711 drug inhibits poliovirus infectivity by blocking capsid uncoating. This antiviral drug

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Picornavirus replication inhibitors, like WIN51711, are believed to prevent poliovirus infectivity.
  • These drugs are thought to bind the viral capsid, inhibiting structural transitions essential for uncoating.

Purpose of the Study:

  • To investigate the mechanism of WIN51711 antiviral activity.
  • To determine the role of capsid structural transitions in poliovirus binding to cellular receptors at reduced temperatures.

Main Methods:

  • Examined WIN51711 activity at temperatures below 37°C, where capsid flexibility is reduced.
  • Assessed the effect of WIN51711 on the binding of wild-type poliovirus and a poliovirus mutant to host cells.

Main Results:

  • WIN51711 inhibited wild-type poliovirus binding to cells at temperatures below 37°C.
  • The drug did not affect the binding of a poliovirus mutant known to undergo structural transitions more readily.
  • These findings indicate that poliovirus capsid structural changes are necessary for cellular receptor binding.

Conclusions:

  • Poliovirus capsid structural transitions are critical for cellular receptor interaction.
  • WIN51711's antiviral mechanism is dependent on the ability of the capsid to undergo these conformational changes.
  • The study provides insight into poliovirus entry mechanisms and potential antiviral targets.

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Engineering Antiviral Agents via Surface Plasmon Resonance13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...